Pharmaceutical Company Successful Scale Up From Trial Stage Lab Mixer To Industrialized Process

A multinational pharmaceutical company was developing a modified virus to be used in treatment to destroy cancerous tumors. To do this they needed equipment that could finely disintegrate and disperse the materials needed to produce the virus.

The milling of the materials is the step which releases the virus, after which it can be extracted and then genetically modified to target and destroy cancerous tumors.

This case study highlights how after a successful trial of a lab mixer at the first stage of process development they worked with a manufacturer to purchase UHS autoclavable design mixers to get the same successful results at a larger scale.